Design Therapeutics, Inc. DSGN Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s free cash flow yield?
- Design Therapeutics, Inc. (DSGN) reported free cash flow yield of -8.2% in Q1 2026.
- How has Design Therapeutics, Inc.'s free cash flow yield changed year-over-year?
- Design Therapeutics, Inc.'s free cash flow yield increased by 62.1% year-over-year, from -21.8% to -8.2%.
- What is the long-term trend for Design Therapeutics, Inc.'s free cash flow yield?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s free cash flow yield has grown at a 40.7% compound annual growth rate (CAGR), from -2.6% to -10.2%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.